Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Amortizatization of Intangibles: 2023-2024

Historic Amortizatization of Intangibles for Whitehawk Therapeutics (WHWK) over the last 2 years, with Dec 2024 value amounting to $1.3 million.

  • Whitehawk Therapeutics' Amortizatization of Intangibles rose 132.04% to $717,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $879,000, marking a year-over-year decrease of 45.20%. This contributed to the annual value of $1.3 million for FY2024, which is 58.51% down from last year.
  • Per Whitehawk Therapeutics' latest filing, its Amortizatization of Intangibles stood at $1.3 million for FY2024, which was down 58.51% from $3.1 million recorded in FY2023.
  • In the past 5 years, Whitehawk Therapeutics' Amortizatization of Intangibles ranged from a high of $3.1 million in FY2023 and a low of $1.3 million during FY2024.
  • For the 2-year period, Whitehawk Therapeutics' Amortizatization of Intangibles averaged around $2.2 million, with its median value being $2.2 million (2023).
  • Data for Whitehawk Therapeutics' Amortizatization of Intangibles shows a maximum YoY tumbled of 58.51% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Whitehawk Therapeutics' Amortizatization of Intangibles stood at $3.1 million in 2023, then plummeted by 58.51% to $1.3 million in 2024.